Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved Trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37278451/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Heart Failure With Reduced Ejection Fraction in the United States - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37270374/
The findings of this study indicate that dapagliflozin may offer greater lifetime economic value when compared with empagliflozin. Given that the current clinical practice guideline does not recommend one SGLT2...
Multimodality Imaging and Biomarker Approach to Characterize the Pathophysiology of Heart Failure in Left Ventricular Non-Compaction with Preserved Ejection Fraction - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37297827/
LVNC patients with HFpEF have diffuse fibrosis, which is more extensive at the apical level, explaining the decrease in apical deformation and overexpression of Galectin-3. Lower transmural and base-to-apex deformation...
Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37297876/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Effects of empagliflozin in women and men with acute myocardial infarction - an analysis from the EMMY trial
Source : https://www.sciencedirect.com/science/article/pii/S1109966623001008?via=ihub
Empagliflozin exerts beneficial cardiac effects in people with acute myocardial infarction. Women with acute myocardial infarction are older and have higher NTproBNP levels than men.
Conclusions: Empagliflozin exhibited similar benefits in women and men when administered immediately after an AMI.